Literature DB >> 28107028

Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy.

Valesca S Koth1, Maria A Figueiredo1, Fernanda G Salum1, Karen Cherubini1.   

Abstract

OBJECTIVES: To analyze the clinical, radiographic and haematological aspects of patients under bisphosphonate therapy.
METHODS: A retrospective study was conducted where the records of patients taking bisphosphonates were analyzed considering the occurrence of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Evaluation included panoramic and periapical radiographies, haematological examinations and clinical features. Radiographies were analyzed determining the presence or absence of bone sclerosis, osteolysis, persisting alveolar socket, narrowing of the mandibular canal, widening of the periodontal ligament space, periradicular radiolucency, sequestrum and thickening of the lamina dura. Laboratory tests consisted of complete blood count, fasting serum glucose, erythrocyte sedimentation rate (ESR) and serum levels of calcium, phosphorus, alkaline phosphatase, parathormone (PTH) and C-terminal telopeptide of collagen I (CTX).
RESULTS: Alkaline phosphatase and ESR were significantly higher in the BRONJ group, whereas fasting serum glucose, CTX, PTH, calcium and phosphorus did not significantly differ. BRONJ showed association with smoking, tooth extraction, anaemia and leukocytosis. On radiographic analysis, persisting alveolar socket, osteolysis, bone sclerosis and narrowing of the mandibular canal were significantly more prevalent in the BRONJ group. Thickening of the lamina dura, periapical radiolucencies, widening of the periodontal ligament space and sequestrum did not significantly differ between the groups.
CONCLUSIONS: BRONJ is a multifactorial disease with high morbidity, which requires experimental studies to clarify the role of the reported risk factors and clinical radiographic signs to improve its diagnosis.

Entities:  

Keywords:  bisphosphonate-associated osteonecrosis of the jaw; diagnostic X-ray; drug-related side effects; haematologic test

Mesh:

Substances:

Year:  2017        PMID: 28107028      PMCID: PMC5595000          DOI: 10.1259/dmfr.20160260

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  59 in total

1.  Biomarkers for Bisphosphonate-Related Osteonecrosis of the Jaw.

Authors:  Jin-Woo Kim; In-Ho Cha; Sun-Jong Kim; Myung-Rae Kim
Journal:  Clin Implant Dent Relat Res       Date:  2015-02-26       Impact factor: 3.932

2.  Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?

Authors:  Luis Junquera; Lorena Gallego
Journal:  J Oral Maxillofac Surg       Date:  2008-07       Impact factor: 1.895

Review 3.  Bisphosphonate related osteonecrosis of the jaws: spontaneous or dental origin?

Authors:  Sarina E C Pichardo; J P Richard van Merkesteyn
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-09

4.  Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.

Authors:  Marcia P Maahs; Alan A Azambuja; Maria M Campos; Fernanda G Salum; Karen Cherubini
Journal:  Head Neck       Date:  2011-02       Impact factor: 3.147

5.  Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.

Authors:  Nathaniel S Treister; Bernard Friedland; Sook-Bin Woo
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-03-29

6.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

7.  Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).

Authors:  Christian Thomas; Magdalena Spanidis; Christina Engel; Frederik C Roos; Sebastian Frees; Andreas Neisius; Christian Hampel; Peter Rubenwolf; Joachim W Thüroff; Christian Walter; Matthias Miederer
Journal:  Clin Oral Investig       Date:  2015-08-26       Impact factor: 3.573

8.  Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study.

Authors:  Makoto Kajizono; Hikaru Sada; Yuhko Sugiura; Yoshihiko Soga; Yoshihisa Kitamura; Junji Matsuoka; Toshiaki Sendo
Journal:  Biol Pharm Bull       Date:  2015       Impact factor: 2.233

9.  Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ).

Authors:  A Bedogni; V Fusco; A Agrillo; G Campisi
Journal:  Oral Dis       Date:  2012-02-22       Impact factor: 3.511

10.  Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma.

Authors:  Y Choi; B Park; K Kim; B C Jeong; S I Seo; S S Jeon; H Y Choi; J E Lee; H M Lee
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

View more
  3 in total

1.  Prevalence of radiographic findings on jaws exposed to antiresorptive therapy: a meta-analysis.

Authors:  Kamile Leonardi Dutra; Letícia Fernanda Haas; Glaucia S Zimmermann; Gilberto Melo; Mariana Comparotto Minamisako; Carlos Flores-Mir; Márcio Corrêa
Journal:  Dentomaxillofac Radiol       Date:  2018-11-07       Impact factor: 2.419

Review 2.  Prevalence of dental alterations in patients under bisphosphonates therapy: a systematic review.

Authors:  Monique Abreu Pauli; Natália Cristina Trentin Bordignon; Geórgia Ribeiro Martini; Mariana Comparotto Minamisako; Rogério Gondak
Journal:  Oral Maxillofac Surg       Date:  2022-06-04

3.  Radiographic predictors for MRONJ in oncologic patients undergoing tooth extraction.

Authors:  Catalina Moreno-Rabié; Laurence Lapauw; Hugo Gaêta-Araujo; André Ferreira-Leite; Wim Coucke; Tim van den Wyngaert; Reinhilde Jacobs
Journal:  Sci Rep       Date:  2022-07-04       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.